Brief: Algernon Pharmaceuticals Announces Appointment Of Harry Bloomfield, Qc. As A New Board Director And Chairman
09/09/2021 13:14
Sept 9 (Reuters) - Algernon Pharmaceuticals Inc AGN.CD :
* ALGERNON PHARMACEUTICALS ANNOUNCES APPOINTMENT OF HARRY
BLOOMFIELD, QC. AS A NEW BOARD DIRECTOR AND CHAIRMAN
Source text for Eikon: ID:nGNXbsWk2J
Further company coverage: AGN.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grey Matters Health
See all newsBrief: Grey Matters Announces The Closing Of Its Equity And Convertible Debenture Private Placement Totalling CAD $1.12 Million
Brief: Algernon Announces Additional Increase To Private Placement Financing
Brief: Algernon Health Announces Private Placement
Brief: Algernon Announces Closing Of The Private Placement Financing
Brief: Algernon Announces $1 Mln Private Placement